Work

[Preliminary evaluation of the efficacy and safety of telitacicept in children with IgA nephropathy].

Year: 2026

Type: article

Abstract: OBJECTIVES: To preliminarily assess the efficacy and safety of telitacicept in pediatric IgA nephropathy (IgAN). METHODS: cells, estimated glomerular filtration rate (eGFR), and glucocorticoid dosage. Adverse events were recorded. RESULTS: >0.05). A total of 6 adverse event episodes were recorded, predominantly mild respiratory infections; no serious adverse events occurred. CONCLUSIONS: Telitacicept can effectively reduce proteinuria in children with IgAN and demonstrates an overall favorable safety profile.

Source: PubMed Central

DOI: 10.7499/j.issn.1008-8830.2602053

Authors: Jie Chen, Xiao-Xia Yu, Xiao-Song Shi, Bing Chen, Shen Wu, Ri-Rong Zhong

Institutions: Fujian Medical University, Fujian Provincial Hospital, Fuzhou University

Language: Chinese

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7223211181